Strides Pharma Science Ltd. (STAR): Strides Pharma Science Share Price near 52-week high as STAR trades at Rs 1,241.90
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
Strides Pharma Science Share Price is trading at Rs 1,241.90, up 2.17% from the previous close, and remains close to its 52-week high with a market capitalisation of Rs 11,400.84 crore. The move places STAR among the closely watched 52 Week High Stocks in the Indian Stock Market today. According to latest Univest data, the price event is clear: the stock is trading near its yearly high, while the latest figures do not establish a company-specific catalyst. For readers tracking Strides Pharma Science Share Price Today, the important point is that the stock is holding well above its prior session reference and is being followed for its price action, valuation and Healthcare sector context. Univest is tracking the move as part of broader Strides Pharma Science Stock News and Strides Pharma Science Share Price Live coverage.
Strides Pharma Science Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,241.9 |
| Previous Close | Rs 1,215.55 |
| Today's Move | +Rs 26.35 (+2.17%) |
| Open | Rs 1,226.8 |
| High | Rs 1,242.4 |
| Low | Rs 1,220.2 |
| Turnover | Rs 0.18 crore |
| Market Capitalisation | Rs 11,400.84 crore |
Strides Pharma Science Ltd. (STAR) traded at Rs 1,241.9 versus the previous close of Rs 1,215.55, a rise of 2.17%. The stock opened at Rs 1,226.8, reached a high of Rs 1,242.4 and touched a low of Rs 1,220.2.
Strides Pharma Science Share Price opened at Rs 1,226.80, moved between Rs 1,220.20 and Rs 1,242.40, and was last at Rs 1,241.90. That compares with the previous close of Rs 1,215.55, leaving the stock up Rs 26.35 for the day. The session range shows that the price stayed near the upper end of trading, while turnover stood at Rs 0.18 crore. On the same reading, STAR is trading just below the day high and near its 52-week high, which is why Strides Pharma Science Share Price Today is drawing attention in Strides Pharma Science Stock News and Strides Pharma Science Share News coverage. The move is visible in the current quote itself, and the stock remains one of the more closely followed names in Strides Pharma Science Share Price Update discussions on Univest.
Strides Pharma Science Ltd. (STAR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 11,400.84 crore |
| P/E Ratio | 18.26x |
| P/B Ratio | 3.42x |
| ROE | 20.31% |
| ROCE | 18.57% |
| EPS | Rs 66.56 |
| Book Value Per Share | Rs 355.18 |
| Dividend Yield | 0.41% |
Strides Pharma Science Ltd. (STAR) fundamental metrics show P/E 18.26x, P/B 3.42x, ROE 20.31%, ROCE 18.57%. These figures provide context only and are not a buy or sell signal.
Strides Pharma Science Ltd. has a market capitalisation of Rs 11400.84 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.26x, P/B at 3.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.31% and ROCE of 18.57%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 66.56, book value per share of Rs 355.18, dividend yield of 0.41%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.44x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 18.26x |
| Benchmark Median P/E | 28.44x |
| Benchmark Average P/E | 41.98x |
| Benchmark P/E Range | 0x to 765.12x |
| Company P/B Ratio | 3.42x |
| Benchmark Median P/B | 2.96x |
| Company ROE | 20.31% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 18.57% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 11,400.84 crore |
| Benchmark Median Market Cap | Rs 718.76 crore |
Strides Pharma Science Ltd. (STAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Strides Pharma Science Ltd. (STAR) has a P/E ratio of 18.26x, which is below the benchmark median of 28.44x, a difference of -35.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Strides Pharma Science Ltd. (STAR) has a ROE of 20.31%, which is above the benchmark median of 11.69%, a difference of +73.74%. Strides Pharma Science Ltd. (STAR) has a ROCE of 18.57%, which is above the benchmark median of 13.32%, a difference of +39.41%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sequent Scientific Ltd. | VIYASH | 11,120.18 | 64.91 | 3.95 | 9.06 | 13.1 |
| Blue Jet Healthcare Ltd. | BLUEJET | 10,970.42 | 47.29 | 4.96 | 19.88 | 27.18 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 12,924.71 | 74.14 | 14.66 | 25.37 | 28.5 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | 12,925.98 | 43.66 | 3.73 | 8.06 | 14.77 |
| CORONA Remedies Ltd. | CORONA | 13,542.68 | 67.1 | 16.55 | 27.36 | 31.74 |
Strides Pharma Science Ltd. (STAR) has a P/E ratio of 18.26x compared with the displayed peer median of 64.91x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.31% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 18.57% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Strides Pharma Science Ltd. (STAR) has a market capitalisation of Rs 11,400.84 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Strides Pharma Science
- Strides Pharma Science Share Price is at Rs 1,241.90, up 2.17% from the previous close.
- The stock is trading near its 52-week high and one-year high.
- Market capitalisation stands at Rs 11,400.84 crore.
- P/E of 18.26 is below the Pharmaceuticals & Drugs industry median of 28.44.
- ROE of 20.31% and ROCE of 18.57% are both above industry medians.
About Strides Pharma Science
Strides Pharma Science Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE as STAR, and its latest market classification is supported by the same industry benchmark used in Univest’s stock coverage. Strides Pharma Science Share Price is therefore being read alongside its valuation, return ratios and company financials rather than in isolation. The latest Univest figures also include revenue and earnings history, which helps readers follow Strides Pharma Science Stock News and Strides Pharma Science Company News in a more structured way.
Frequently Asked Questions
Why is Strides Pharma Science Share Price in focus today?
Ans. Strides Pharma Science Share Price is in focus because it is trading at Rs 1,241.90, up 2.17%, and remains close to its 52-week high. The latest move is visible in the quote and session range.
What is Strides Pharma Science Share Price today?
Ans. Strides Pharma Science Share Price today is Rs 1,241.90. The stock is above the previous close of Rs 1,215.55, and the latest reading places STAR near its yearly high in Univest coverage.
How much did STAR move in the latest trading update?
Ans. STAR moved up Rs 26.35, which equals 2.17% on the day. The move comes with a session high of Rs 1,242.40 and a low of Rs 1,220.20, based on the latest figures.
What is the market capitalisation of Strides Pharma Science?
Ans. Strides Pharma Science has a market capitalisation of Rs 11,400.84 crore. That places it above the industry median market capitalisation of Rs 718.76 crore in the same industry benchmark set.
How does Strides Pharma Science look on valuation?
Ans. The company’s P/E ratio is 18.26 and its P/B ratio is 3.42. On the latest Univest figures, P/E is below the industry median of 28.44, while P/B is above the median of 2.96.
What do ROE and ROCE show for STAR?
Ans. STRIDE Pharma Science reports ROE of 20.31% and ROCE of 18.57%. Both are above the industry medians of 11.69% and 13.32%, which adds context to Strides Pharma Science Stock Analysis.
How does Strides Pharma Science compare with Healthcare peers?
Ans. Strides Pharma Science Share Price trades with a lower P/E than several peers such as Sequent Scientific, Blue Jet Healthcare and Sudeep Pharma. Its ROE and ROCE sit in a competitive range within the peer set.
Where can I track Strides Pharma Science Share Price live?
Ans. You can track Strides Pharma Science Share Price live on Univest, where the stock page combines market price, 52-week levels, valuation ratios, sector context and related Strides Pharma Science Stock News in one view.
Track Strides Pharma Science Share Price on Univest
Use Strides Pharma Science Ltd. (STAR) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Strides Pharma Science Share Price on Univest for live share price updates, key ratios, market capitalisation, 52-week levels, valuation context and sector comparison. Univest also brings together Strides Pharma Science Share Price Today, fundamental analysis and stock news in one place for quick reference.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
